Critically, "Many patients regain two-thirds of their weight when coming off of these medications." These represent "not a quick fix for weight loss" but require "a commitment to regular injections and ongoing monitoring." 4
[16] [17] Semaglutide (as Wegovy) is further indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with obesity (initial BMI 30 kg/m 2 ) or who are overweight (initial BMI 27 kg/m 2 ) and have at least one weight-related comorbidity such as dysglycemia (prediabetes or type 2 diabetes), hypertension, dyslipidemia, or cardiovascular disease
This critical repair process supports much more efficient ATP (cellular energy) production, potentially raising the patient's baseline threshold for physical exertion and significantly reducing the severity, duration, and frequency of debilitating energy crashes and PEM
When combined with insulin or sulfonylureas, semaglutide can raise hypoglycemia risk, so dose adjustments of glucose-lowering drugs are often needed
Exosomes also play a key role in tissue repair